Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

[Lung cancer metastases to the brain: clinical and morphological prognostic factors].

Rotin DL, Paklina OV, Kobiakov GL, Shishkina LV, Kravchenko ÉV, Stepanian MA.

Zh Vopr Neirokhir Im N N Burdenko. 2013;77(1):24-8; discussion 29. Russian.

2.

Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.

Caballero JA, Sneed PK, Lamborn KR, Ma L, Denduluri S, Nakamura JL, Barani IJ, McDermott MW.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):303-9. doi: 10.1016/j.ijrobp.2011.06.1987. Epub 2011 Nov 11.

PMID:
22079723
3.

Pronostic factors of synchronous brain metastases from lung cancer.

Penel N, Brichet A, Prevost B, Duhamel A, Assaker R, Dubois F, Lafitte JJ.

Lung Cancer. 2001 Aug-Sep;33(2-3):143-54.

PMID:
11551409
4.

Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis.

Kepka L, Cieslak E, Bujko K, Fijuth J, Wierzchowski M.

Acta Oncol. 2005;44(4):389-98.

PMID:
16120548
5.

Surgical treatment of brain metastases of lung cancer: retrospective analysis of 89 cases.

Nakagawa H, Miyawaki Y, Fujita T, Kubo S, Tokiyoshi K, Tsuruzono K, Kodama K, Higashiyama M, Doi O, Hayakawa T.

J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):950-6. Review.

6.

Radiosurgery for brain metastases from primary lung carcinoma.

Hoffman R, Sneed PK, McDermott MW, Chang S, Lamborn KR, Park E, Wara WM, Larson DA.

Cancer J. 2001 Mar-Apr;7(2):121-31.

PMID:
11324765
7.

Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.

Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM, Mehta M.

Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):655-61. doi: 10.1016/j.ijrobp.2009.08.025. Epub 2009 Nov 26.

PMID:
19942357
8.

Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.

Nieder C, Andratschke N, Grosu AL, Molls M.

Strahlenther Onkol. 2003 Jan;179(1):16-20.

PMID:
12540980
9.

Brain metastases and non-small cell lung cancer. Prognostic factors and correlation with survival after irradiation.

Rodrigus P, de Brouwer P, Raaymakers E.

Lung Cancer. 2001 May;32(2):129-36.

PMID:
11325483
10.

Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.

Berghoff AS, Ilhan-Mutlu A, Dinhof C, Magerle M, Hackl M, Widhalm G, Hainfellner JA, Dieckmann K, Pichler J, Hutterer M, Melchardt T, Bartsch R, Zielinski CC, Birner P, Preusser M.

Neuropathol Appl Neurobiol. 2015 Feb;41(2):e41-55. doi: 10.1111/nan.12185.

PMID:
25256708
11.

Validity of the graded prognostic assessment-derived index to predict brain-metastatic patients' survival after Gamma Knife radiosurgery.

Chiou SM.

Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1156-62. doi: 10.1016/j.ijrobp.2009.09.028.

PMID:
20970031
12.

Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors.

Sheehan J, Kondziolka D, Flickinger J, Lunsford LD.

J Neurosurg. 2005 Jan;102 Suppl:247-54.

PMID:
15662819
13.

Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases.

Guo S, Reddy CA, Chao ST, Suh JH, Barnett GH, Vogelbaum MA, Videtic GM.

Lung Cancer. 2012 Aug;77(2):389-93. doi: 10.1016/j.lungcan.2012.03.028. Epub 2012 Apr 27.

PMID:
22542706
14.

Efficacy of X-ray stereotactic radiotherapy on brain metastases and prognostic analysis.

Wei W, Deng ML, Wu SX, Zeng ZF, Li FY, Wang HY, Bao Y, Gao YH, Chen LX.

Chin J Cancer. 2010 Feb;29(2):202-6.

15.

Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.

Viani GA, Castilho MS, Salvajoli JV, Pellizzon AC, Novaes PE, Guimarães FS, Conte MA, Fogaroli RC.

BMC Cancer. 2007 Mar 26;7:53.

16.

Identification of prognostic factors in patients with brain metastases: a review of 1292 patients.

Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI.

Int J Radiat Oncol Biol Phys. 1999 Mar 1;43(4):795-803. Review.

PMID:
10098435
17.

Gamma knife radiosurgery for multiple brain metastases from lung cancer.

Park SH, Hwang SK, Kang DH, Lee SH, Park J, Hwang JH, Hamm IS, Park YM.

J Clin Neurosci. 2009 May;16(5):626-9. doi: 10.1016/j.jocn.2008.08.003. Epub 2009 Mar 5.

PMID:
19268596
18.

Gamma knife surgery for brain metastases: indications for and limitations of a local treatment protocol.

Serizawa T, Saeki N, Higuchi Y, Ono J, Iuchi T, Nagano O, Yamaura A.

Acta Neurochir (Wien). 2005 Jul;147(7):721-6; discussion 726. Epub 2005 May 20.

PMID:
15891808
19.

Surgical treatment for brain metastases: Prognostic factors and survival in 309 patients with regard to patient age.

Stark AM, Stöhring C, Hedderich J, Held-Feindt J, Mehdorn HM.

J Clin Neurosci. 2011 Jan;18(1):34-8. doi: 10.1016/j.jocn.2010.03.046. Epub 2010 Sep 20.

PMID:
20851611
20.

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.

Ring BZ, Seitz RS, Beck RA, Shasteen WJ, Soltermann A, Arbogast S, Robert F, Schreeder MT, Ross DT.

Mod Pathol. 2009 Aug;22(8):1032-43. doi: 10.1038/modpathol.2009.60. Epub 2009 May 8.

Supplemental Content

Support Center